Piper Jaffray Upgrades Marker Therapeutics (MRKR) to Overweight
Tweet Send to a Friend
Piper Jaffray analyst Edward Tenthoff upgraded Marker Therapeutics (NASDAQ: MRKR) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
